Eli Lilly Launches Multi-Dose Zepbound Pen to Drive Obesity Drug Growth
Eli Lilly unveiled a new multi-dose version of its blockbuster obesity drug Zepbound, allowing patients to receive a full month of doses in a single injection.
More Videos
Elon Musk’s $17 Billion AI Chip Bet: Inside The Terafab Plan
Barron’s Associate Editor Al Root breaks down Elon Musk’s Terafab plan, its massive scale and what it could mean for Tesla, SpaceX and xAI.
How To Shop Amazon Prime Day Like A Pro
Trae Bodge, shopping expert at TrueTrae.com, shares how to spot real Prime Day deals and when shoppers should buy Halloween and holiday items.
Inside The White House’s “Super Intelligence” AI Deal: What It Means For The Future Of Tech
Axios Tech Policy Reporter Maria Curi breaks down the White House’s “Super Intelligence” accord and what it means for AI safety and regulation.
The Robotics Boom: How Chang Robotics Is Rebuilding American Manufacturing
Chang Robotics CEO Matt Chang discusses physical AI, automated factories and the push to reshore critical manufacturing to the U.S.
The 2030 Deadline: Why NYC's Buildings Are Racing the Climate Clock
NYC's buildings are on the climate clock. Urban Green Council breaks down lobby letter grades, Local Law 97, smart tech and the city's race to net zero.
The Job Market’s Next Chapter: Where Workers Are Still in Demand
Kory Kantenga, Head of Economics, Americas at LinkedIn, breaks down hiring trends, labor-market resilience and where employers are still seeking workers.
